Serge Saxonov - 07 Sep 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact
Issuer symbol
TXG
Transactions as of
07 Sep 2021
Net transactions value
-$2,687,578
Form type
4
Filing time
09 Sep 2021, 17:28:50 UTC
Previous filing
25 Aug 2021
Next filing
07 Oct 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Gift $0 -360 -7.4% $0.000000 4,498 26 Aug 2021 See Footnote F1, F2
transaction TXG Class A Common Stock Options Exercise $26,253 +5,209 +0.58% $5.04* 903,677 07 Sep 2021 Direct F3, F4
transaction TXG Class A Common Stock Options Exercise $112,401 +9,791 +1.1% $11.48 913,468 07 Sep 2021 Direct F3
transaction TXG Class A Common Stock Sale $129,146 -700 -0.08% $184.49 912,768 07 Sep 2021 Direct F3, F5
transaction TXG Class A Common Stock Sale $222,604 -1,200 -0.13% $185.50 911,568 07 Sep 2021 Direct F3, F6
transaction TXG Class A Common Stock Sale $504,564 -2,702 -0.3% $186.74 908,866 07 Sep 2021 Direct F3, F7
transaction TXG Class A Common Stock Sale $379,585 -2,025 -0.22% $187.45 906,841 07 Sep 2021 Direct F3, F8
transaction TXG Class A Common Stock Sale $266,550 -1,414 -0.16% $188.51 905,427 07 Sep 2021 Direct F3, F9
transaction TXG Class A Common Stock Sale $531,470 -2,800 -0.31% $189.81 902,627 07 Sep 2021 Direct F3, F10
transaction TXG Class A Common Stock Sale $715,863 -3,759 -0.42% $190.44 898,868 07 Sep 2021 Direct F3, F11
transaction TXG Class A Common Stock Sale $76,450 -400 -0.04% $191.12 898,468 07 Sep 2021 Direct F3, F12
holding TXG Class A Common Stock 89,960 07 Sep 2021 See Footnote F13

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXG Stock Option (right to buy) Options Exercise $0 -5,209 -7% $0.000000 68,948 07 Sep 2021 Class A Common Stock 5,209 $5.04 Direct F3, F14
transaction TXG Stock Option (right to buy) Options Exercise $0 -9,791 -14% $0.000000 58,130 07 Sep 2021 Class A Common Stock 9,791 $11.48 Direct F3, F15
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As of June 4, 2021, 4,858 shares of Class A Common Stock were held by the Andromeda Trust, for which the Reporting Person and his spouse serve as trustees (the "Andromeda Trust"), and which shares were received upon transfer from the Reporting Person. Following the disposition by gift of 360 shares on August 26, 2021, the Andromeda Trust holds 4,498 shares of Class A Common Stock.
F2 The shares are held by the Andromeda Trust.
F3 The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
F4 Reflects the transfer by the Reporting Person of 4,858 shares of Class A Common Stock to the Andromeda Trust, as referenced in footnote (1).
F5 This transaction was executed in multiple trades at prices ranging from $184.00 to $184.855. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F6 This transaction was executed in multiple trades at prices ranging from $185.015 to $185.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F7 This transaction was executed in multiple trades at prices ranging from $186.105 to $187.095. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F8 This transaction was executed in multiple trades at prices ranging from $187.11 to $188.075. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F9 This transaction was executed in multiple trades at prices ranging from $188.155 to $189.06. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F10 This transaction was executed in multiple trades at prices ranging from $189.20 to $190.02. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F11 This transaction was executed in multiple trades at prices ranging from $190.08 to $191.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F12 This transaction was executed in multiple trades at prices ranging from $191.09 to $191.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F13 The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
F14 This option, originally for 250,000 shares, of which 181,052 have been exercised, vested as to one forty-eighth of the shares on October 1, 2018, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F15 This option, originally for 145,786 shares, of which 87,656 have been exercised, vested as to one forty-eighth of the shares on May 1, 2019, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.